Researchers examined the records of Beth Israel Deaconess Medical Center in Boston and found that 4.9% of patients who received acid reflux drugs developed pneumonia, compared with 2% of those who did not take the drugs. AstraZeneca, maker of heartburn drug Nexium, said the findings do not clearly demonstrate that proton pump inhibitors caused excess pneumonia.

Full Story:

Related Summaries